StockData
Lifeward Ltd. logo

Lifeward Ltd. (LFWD) stock

LFWDNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3066% below fair value
$4.06−1.66 (-29.02%)

Close on Nov 13, 2026Market cap $11.50MP/E –Yield –

Lifeward Ltd. saw revenue fall 14.1% to $21.06M over the twelve months to Sep 30, 2026. Free cash flow was -$19.64M. At the latest close the market valued the company at $11.50M.

Revenue
$21.06M
-14.1% vs. a year earlier
Operating income
-$25.58M
TTM Q3 2026
Free cash flow
-$19.64M
TTM Q3 2026
EPS, diluted
-$15.73
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$11.50M
P/E ratio
–
Price to sales
0.55
Price to book
1.58
Dividend yield
–
Free cash flow yield
-170.79%

Fundamentals

Revenue
$21.06M
Net income
-$32.71M
EPS, diluted
-$15.73
Free cash flow
-$19.64M
Book value per share
$1.89
Diluted shares
4M

Trading

Next earnings
Mar 17, 2027 (estimated, before the open)
Previous close
$5.72
Open
$5.42
Day's range
$3.81 – $5.42
Volume
30,456
Average volume (20 days)
22,329
Beta (5 years)
1.06
52-week range
$3.81 – $9.61
RSI (14 days)
23.7
Volatility (1 year)
80.0%
Relative volume
3.16×
WACC
10.4%

Market cap history

Month-end market cap since 2014, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodLFWDS&P 500DifferenceLFWD per yearS&P 500 per year
1 month-33.4%-3.0%−30.4 pts
3 months-48.6%-2.8%−45.8 pts
Year to date-41.3%+11.5%−52.8 pts
1 year-35.0%+13.5%−48.5 pts
3 years-93.1%+77.7%−170.8 pts-59.0%+21.1%
5 years-96.8%+72.6%−169.4 pts-49.8%+11.5%
10 years-99.9%+308.2%−408.1 pts-51.4%+15.1%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$21.06M-14.1% YoY

Gross profit

$6.63M-27.9% YoY

Operating income

-$25.58M

Net income

-$32.71M

EPS, diluted

-$15.73

Free cash flow

-$19.64M
Reported periodTrailing twelve months

Press releases

Releases Lifeward filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Lifeward

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Lifeward Ltd. develops, manufactures, and markets medical devices and robotic systems designed for physical rehabilitation, recovery, and mobility. Its product portfolio includes ReWalk Personal and Rehabilitation powered exoskeletons for individuals with spinal cord injuries and paraplegia, AlterG Anti-Gravity Systems for physical therapy and athletic training, and MyoCycle functional electrical stimulation cycles. The company also offers extended warranties, product leasing, maintenance services, and related consumable accessories. Its target customers comprise rehabilitation clinics, physical therapy centers, healthcare facilities, and individual end-users requiring personal mobility assistance.

Company profile, executives and history

Lifeward stock: common questions

What is Lifeward's stock price?

LFWD closed at $4.06 on Nov 13, 2026, down 29.02% on the day. Over the past 52 weeks it traded between $3.81 and $9.61.

What is Lifeward's market cap?

Lifeward was worth $11.50M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

What is LFWD's P/E ratio?

Lifeward lost money over the twelve months to Sep 30, 2026 (diluted EPS -$15.73), so it has no meaningful P/E ratio.

How much revenue does Lifeward make?

Lifeward reported revenue of $21.06M for the twelve months to Sep 30, 2026, down 14.1% from a year earlier.

Does Lifeward pay a dividend?

No. Lifeward has not paid a cash dividend over the last twelve months.

When does Lifeward report earnings next?

Lifeward is expected to report Q4 FY2026 results on Mar 17, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has LFWD stock performed over the past year?

Including dividends, LFWD returned -35.0% over the past year, against +13.5% for the S&P 500.

How many LFWD shares are sold short?

0M shares were sold short at the latest FINRA report, 31.86% of the float, or 5.0 days of average trading volume.

Who are Lifeward's competitors?

Companies most similar to Lifeward by business, industry and size include MYO, ZJYL, APT, MLSS, HYPR.

See a number that looks wrong?